OKYO OKYO
Company Profile ↓Company Overview
OKYO (OKYO) is a publicly traded company listed on with a market capitalization of $82.39M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.18.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -49.03% |
| 6 Months: | -25.24% |
| 3 Months: | -1.88% |
| 1 Month: | -10.29% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)48.80 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 52.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 13.19M | 15.75M | 7.09M | 8.50M |
| Operating Income | - | -13.19M | -15.75M | -7.09M | -8.50M |
| EBITDA | - | -13.18M | -15.75M | -7.10M | -8.47M |
| Interest Expense | - | 96.69K | 1.05M | 870.28K | 473.94K |
| Pretax Income | - | -13.28M | -16.80M | -7.97M | -8.94M |
| Tax Provision | - | -12.20K | 22.42K | -3.26M | 7.99K |
| Net Income | - | -13.27M | -16.83M | -4.71M | -8.95M |
| Diluted EPS | - | -0.61 | -0.57 | -0.12 | -0.24 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 5.20M | 1.54M | 3.68M | 20.98M |
| Current Assets | - | 5.20M | 1.54M | 3.68M | 20.97M |
| Cash & Equivalents | - | 4.05M | 826.85K | 1.56M | 14.59M |
| Inventory | - | - | - | - | - |
| Receivables | - | 980.08K | 580.94K | 1.89M | 170.67K |
| Total Liabilities | - | 7.26M | 7.42M | 9.23M | 8.64M |
| Current Liabilities | - | 7.26M | 7.42M | 9.23M | 8.64M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | 0 | 2.22M | - | - | - |
| Total Equity | - | -2.05M | -5.88M | -5.55M | 12.34M |
| Shares Outstanding | - | 51.04M | 33.34M | 36.02M | 52.48M |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -7.70M | -9.49M | -1.81M | -5.94M |
| Investing Cash Flow | - | -5.92K | 0 | -1.21K | -6.01M |
| Financing Cash Flow | - | 9.32M | 6.21M | 2.66M | 25.02M |
| Capital Expenditure | -1.67K | -5.92K | - | -1.21K | -6.08K |
| Free Cash Flow | - | -7.70M | -9.49M | -1.81M | -5.94M |
| Net Change in Cash | - | 1.62M | -3.28M | 843.60K | 13.08M |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | - | - | - | - |
| ROE % | - | 646.4% | 286.2% | 84.8% | -72.6% |
| ROCE % | - | 642.3% | 267.9% | 127.8% | -68.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for OKYO
Price to sales forward of OKYO Pharma Limited – NASDAQ:OKYO - TradingView
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPaWpoczdYcEM5dzY2SXJXUlJCYWdvLU5mVFlld1ZkT0loR1E0dVh6aFQwcUtnc0dBclotUExicXlNZUZoV01UNnpuMDl1RkFScXhzV2cxdm9Sd3pmaXZKbjZWVjktQW5SSEhrakVzMnZHMEFaMXhlaEFtRENEaFZXdHRXcDh2cWtHS3VyU1…
What Makes OKYO Pharma (OKYO) a New Buy Stock - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxOLVJ0SlJUelVjZTB1UXNoMTNoTG5tWklEUnBNSTFwMlB5b1lxNWtST2FMb2xFTzd1SE1weHJCODJMWkZCQlpFRFVJMWxtMUN3S2YwUW00WGhLV3JCUXFMZmNNMnlfYkpPRmotX1FtZzNEUTBveXo1MEFlSzlHUTdTWWtKRzQ5c1FTVXBaSE…
OKYO Pharma scientist's holdings reach 20,030 shares after purchase - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPUi0tVFU3cUx1aTdRb3ZIbE9qWHNPXzZBTGZjTHhBMEQtOE1UcTh4SHNuWHZmVl9tUDUxNFRrWnpwSV9SY1dTS1RibS1OMUtueTY0RFpoRjg0a2J3VnVzT3hadHBFOEMyc1ZVYTVEUXVUS3VZbjJ3Q3lXcE5VTG1UZXZKQTRXWDBnd2RZY3…
OKYO Pharma Director John Brancaccio Purchases 5,000 Shares on Nasdaq - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPQkVxRUVRSmpFdmVJbWJxblFGbl9YdUs0NEd4MUpDMXZIdzRqaHcwN3lHLVhlTUF5VnZ1U0NLUDJnVmZPVHROZ0JWV0k3azNidmpvTGNTNGRUNldZaUlUazJfb1YzM3ExNXVSQm5nMmY4b283Ty1lVlFiYm9VUkNfQnBzMnFsS09lbXNDOE…
OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer - GlobeNewswire
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxNY2pMVE5RZVFSM21OUC1BTHNBdmM0NWZJckFxRVJ4NGdNMUExeDFicXZTaXkzTnJfWE1NYzFzcnpZNTl2Y0RlaC1hT2pYbEt6dXptSjBscUZBRGNEMmdSS1NXSmxkSGRaRDZlMWZ4VlpGZEd4eWVVaXJCNlg3YzBmSWVVRklhbm0wSnNhWk…
OKYO Pharma director lifts holding to 112,420 shares - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxQY1g3cUlzVF90TTUxOVJkd2dWNzFEWElyNVlMY0xPc01OVGhkSnVoSzQ4TWlDelBvWnNBanRPOGJIRVNVcmJtRW1qSm5IbG0wV2VWdnIzZjdNWTVENDFtREFTUC1wNnBpS2VrTXhkTGg5aXpVTkRtYmtiQWp4WnYwZ0pzbF9TUnY5bnAzd1…
OKYO — Frequently Asked Questions
What is the current share price of OKYO?
As of 2026-08-05 17:25 PDT, OKYO trades at $1.57 on NASDAQ/NYSE. Its 52-week range is $1.37 to $3.27.
What is the market capitalisation of OKYO?
OKYO has a market capitalisation of $82.39M on NASDAQ/NYSE.
What is the P/E ratio of OKYO?
OKYO trades at a trailing price-to-earnings (P/E) ratio of -6.54. Its price-to-book (P/B) ratio is 6.68.
What is the return on equity (ROE) of OKYO?
OKYO has a return on equity (ROE) of -72.55%. Its return on capital employed (ROCE) is -68.91%.
Is OKYO a good stock to buy?
This page provides a data-driven analysis of OKYO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.